Showing results 214 to 233 of 326
< previous
next >
| Issue Date | Title | Author(s) |
| 2020-01-18 | Obesity and Diabetes: Pathophysiology of Obesity-Induced Hyperglycemia and Insulin Resistance | Gupta, G; Wadhwa, R; Pandey, P; Singh, SK; Gulati, M; Satija, S; Mehta, M; Singh, AK; Dureja, H; Collet, T; Pabreja, K; Chellappan, DK; Dua, K |
| 2022-10 | Oligonucleotides: A novel area of interest for drug delivery in neurodegenerative diseases | Alharbi, KS; Javed Shaikh, MA; Afzal, O; Alfawaz Altamimi, AS; Hassan almalki, W; Kazmi, I; Al-Abbasi, FA; Alzarea, SI; Babu, MR; Singh, SK; Chellappan, DK; Dua, K; Gupta, G |
| 2022-01-01 | One-step synthesis of picolinohydrazides from fusaric acid: DFT, structural characterization and molecular inhibitory studies on metastatic tumor-derived exosomal and non-exosomal proteins | Anand, K; Ramesh, M; Singh, T; Balakumar, C; Chithravel, V; Prasher, P; Katari, NK; Gupta, G; Singh, SK; Chellappan, DK; Dua, K; Chavda, V; Laishevtcev, A; Shahbaaz, M; Abdellattif, MH; Saravanan, M; Chuturgoon, AA |
| 2024-02-16 | Opening avenues for treatment of neurodegenerative disease using post-biotics: Breakthroughs and bottlenecks in clinical translation. | Bashir, B; Alam, S; Khandale, N; Birla, D; Vishwas, S; Pandey, NK; Gupta, G; Paudel, KR; Dureja, H; Kumar, P; Singh, TG; Kuppusamy, G; Zacconi, F; Pinto, TDJA; Dhanasekaran, M; Gulati, M; Dua, K; Singh, SK |
| 2020-12-27 | Opening eyes to therapeutic perspectives of bioactive polyphenols and their nanoformulations against diabetic neuropathy and related complications. | Khursheed, R; Singh, SK; Wadhwa, S; Gulati, M; Kapoor, B; Awasthi, A; Kr, A; Kumar, R; Pottoo, FH; Kumar, V; Dureja, H; Anand, K; Chellappan, DK; Dua, K; Gowthamarajan, K |
| 2022-01-01 | Optimization Studies on Imatinib Mesylate Loaded Nanoliposomes Using Box-Behnken Design | Dahiya, M; Awasthi, R; Gupta, G; Singh, SK; Gulati, M; Jha, NK; Jha, SK; Sharma, A; Prasher, P; Anand, K; Chellappan, DK; Dua, K; Dureja, H |
| 2016 | Oral Delivery of Antidiabetic Polypeptide-k: Journey so far and the Road Ahead. | Kaur, P; Garg, V; Gulati, M; Singh, SK |
| 2022-09-01 | Orally administered solasodine, a steroidal glycoalkaloid, suppresses ovalbumin-induced exaggerated Th2-immune response in rat model of bronchial asthma | Arora, P; Nainwal, LM; Gupta, G; Singh, SK; Chellappan, DK; Oliver, BG; Dua, K |
| 2022-02-11 | Orchestration of Obesolytic Activity of Microbiome: Metabiotics at Centre Stage. | Kapoor, B; Singh, A; Gulati, M; Singh, SK; Rani, P; Alzahrani, Q; Dua, K; Dureja, H; Corrie, L |
| 2022-01-12 | Overcoming drug delivery barriers and challenges in topical therapy of atopic dermatitis: A nanotechnological perspective. | Hemrajani, C; Negi, P; Parashar, A; Gupta, G; Jha, NK; Singh, SK; Chellappan, DK; Dua, K |
| 2021-12-16 | Overcoming hydrolytic degradation challenges in topical delivery: Non-aqueous nano-emulsions. | Kadukkattil Ramanunny, A; Singh, SK; Wadhwa, S; Gulati, M; Kapoor, B; Khursheed, R; Kuppusamy, G; Dua, K; Dureja, H; Chellappan, DK; Jha, NK; Gupta, PK; Vishwas, S |
| 2020-12-01 | Overcoming the dissolution rate, gastrointestinal permeability and oral bioavailability of glimepiride and simvastatin co-delivered in the form of nanosuspension and solid self-nanoemulsifying drug delivery system: A comparative study | Pandey, NK; Singh, SK; Gulati, M; Kumar, B; Kapoor, B; Ghosh, D; Kumar, R; Khursheed, R; Awasthi, A; Kuppusamy, G; Wadhwa, S; Satija, S; Dureja, H; Jain, SK; Chellappan, DK; Anand, K; Mehta, M; Dua, K |
| 2021-10 | Peptides-based therapeutics: emerging potential therapeutic agents for COVID-19 | Shah, JN; Guo, G-Q; Krishnan, A; Ramesh, M; Katari, NK; Shahbaaz, M; Abdellattif, MH; Singh, SK; Dua, K |
| 2022-04-01 | PEPTIDYLARGININE DEIMINASE-4: MEDICO-FORMULATIVE STRATEGY TOWARDS MANAGEMENT OF RHEUMATOID ARTHRITIS | Thirugnanasambandham, I; Radhakrishnan, A; Kuppusamy, G; Singh, SK; Dua, K |
| 2020-08-06 | Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics. | Tan, YY; Yap, PK; Xin Lim, GL; Mehta, M; Chan, Y; Ng, SW; Kapoor, DN; Negi, P; Anand, K; Singh, SK; Jha, NK; Lim, LC; Madheswaran, T; Satija, S; Gupta, G; Dua, K; Chellappan, DK |
| 2022-05 | Pharmacological evaluation of bromelain in mouse model of Alzheimer's disease. | Kumar, R; Kumar, R; Sharma, N; Khurana, N; Singh, SK; Satija, S; Mehta, M; Vyas, M |
| 2022 | PI3K/Akt/mTOR Pathways Inhibitors with Potential Prospects in Non-Small-Cell Lung Cancer. | Alharbi, KS; Shaikh, MAJ; Almalki, WH; Kazmi, I; Al-Abbasi, FA; Alzarea, SI; Imam, SS; Alshehri, S; Ghoneim, MM; Singh, SK; Chellappan, DK; Oliver, BG; Dua, K; Gupta, G |
| 2024-02 | Plant-based therapeutics for chronic obstructive pulmonary diseases: Nanoformulation strategies to overcome delivery challenges | Kokkinis, S; Singh, M; Paudel, KR; De Rubis, G; Bani Saeid, A; Jessamine, V; Datsyuk, J; Singh, SK; Vishwas, S; Adams, J; Hansbro, PM; Oliver, B; Gupta, G; Dureja, H; Dua, K |
| 2023-03 | Polymeric micelles as potent islet amyloid inhibitors: current advances and future perspectives | Kaur, J; Gulati, M; Kaur, IP; Patravale, V; Dua, K; Singh, SK |
| 2022-07-01 | Polymeric micelles loaded with glyburide and vanillic acid: I. Formulation development, in-vitro characterization and bioavailability studies | Kaur, J; Gulati, M; Famta, P; Corrie, L; Awasthi, A; Saini, S; Khatik, GL; Bettada, VG; Madhunapantula, SV; Paudel, KR; Gupta, G; Chellappan, DK; Arshad, MF; Adams, J; Gowthamarajan, K; Dua, K; Hansbro, PM; Singh, SK |
